Growth Metrics

Palisade Bio (PALI) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 60.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 85.14%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -15.72%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 74.39%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.23%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 158.60%
10 Palisade Bio 439.25 Mn 309.68 Mn - -66.74%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -66.74%
Dec 31, 2025 -32.05%
Sep 30, 2025 -13.41%
Jun 30, 2025 48.07%
Mar 31, 2025 26.64%
Dec 31, 2024 13.29%
Sep 30, 2024 -17.69%
Jun 30, 2024 -59.12%
Mar 31, 2024 9.81%
Dec 31, 2023 16.94%
Sep 30, 2023 12.43%
Jun 30, 2023 32.34%
Mar 31, 2023 6.32%
Dec 31, 2022 -8.22%
Sep 30, 2022 -10.71%
Jun 30, 2022 57.91%
Mar 31, 2022 -201.12%
Dec 31, 2021 -97.35%
Sep 30, 2021 -216.00%
Jun 30, 2021 -1,046.77%
Mar 31, 2021 25.49%
Dec 31, 2020 24.45%
Sep 30, 2020 54.20%
Jun 30, 2020 59.03%
Mar 31, 2020 -0.70%
Dec 31, 2019 -23.58%
Sep 30, 2019 -14.02%
Jun 30, 2019 34.87%
Mar 31, 2019 9.80%
Dec 31, 2018 27.47%
Sep 30, 2018 49.92%
Jun 30, 2018 25.15%
Mar 31, 2018 58.36%
Dec 31, 2017 43.97%
Sep 30, 2017 25.76%
Jun 30, 2017 5.61%
Mar 31, 2017 -27.17%
Dec 31, 2016 -4.64%
Sep 30, 2016 18.74%
Jun 30, 2016 25.66%
Mar 31, 2016 26.09%
Dec 31, 2015 -12.04%
Sep 30, 2015 -77.60%
Jun 30, 2015 -99.18%
Mar 31, 2015 -73.98%
Dec 31, 2014 -40.57%
Sep 30, 2014 -38.25%
Jun 30, 2014 28.20%
Mar 31, 2014 -7.96%
Dec 31, 2013 1.68%
Sep 30, 2013 -57.97%
Jun 30, 2013 -37.76%
Mar 31, 2013 -19.62%
Dec 31, 2012 -41.26%
Sep 30, 2012 21.71%
Jun 30, 2012 -10.27%
Mar 31, 2012 8.21%
Dec 31, 2011 35.17%
Sep 30, 2011 22.91%